Searchable abstracts of presentations at key conferences in endocrinology

ea0034oc1.2 | Young Endocrinologists prize session | SFEBES2014

Characterisation of adrenocortical progenitor cells: isolation of mesenchymal stem cell-like cell populations from human adrenal cortex

Gan Earn , Robson Wendy , Lennard Thomas , Pearce Simon , Oldershaw Rachel

Background: The plasticity of adrenal cortex suggests the presence of adrenocortical stem cells (ACSC) but the exact in vivo identity of ACSC remains elusive. A few studies have demonstrated the differentiation of adipose or bone marrow-derived mesenchymal stem cells (MSC) into steroid-producing cells. We therefore investigated the direct isolation of MSC from human adrenal cortex.Methods: Adrenals were obtained as discarded surgical material. S...

ea0034p36 | Clinical biochemistry | SFEBES2014

The effects of climate on the incidence of thiazide diuretic induced hyponatraemia in the UK

Redford Christopher , Skinner Thomas , Rys Andrzej , Smith Jamie

Although TIH is a well-established complication of this drug class, the extent of this problem and the serious morbidity that can result is often not appreciated. At our centre, we became aware of three serious cases of TIH over a 2-week period during the ‘heat wave’ in July 2013. In at least one of these cases excessive water drinking was a clear precipitant. We therefore determined the incidence of TIH at our hospital and in particular whether there is a seasonal e...

ea0034p152 | Clinical practice/governance and case reports | SFEBES2014

Cushing's disease with hepatic adrenal rests

Border Daniel , Aftab Saboor , Pelluri Lavanya , Barber Thomas , Randeva Harpal

We present the case of a 58-year-old woman who presented 30 years ago. She was noted to have abdominal obesity, moon-face and skin bruising/thinning, as well as hypertension. Serum cortisol was elevated and she was presumed to have Cushing’s disease (although we have no record of dynamic tests or imaging from the time of her original presentation). Owing to her desire for future fertility, she underwent bilateral adrenalectomy at the age of 31 years. She received hydrocor...

ea0034p236 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

The characteristics of a patient population with extreme and complex obesity attending a specialist weight management service

Leong Wen Bun , Adab Peymane , Thomas Neil G , Taheri Shahrad

It is important for a specialist weight management service to provide a holistic patient-oriented assessment and treatment plan. To achieve this goal, we performed a service evaluation of the characteristics of patients with extreme and complex obesity attending a specialist weight management service. Anonymised data on 126 patients who attended the Heart of England NHS Foundation Trust specialist weight management service were collected. The patients, with mean age 45.2±...

ea0070aep685 | Pituitary and Neuroendocrinology | ECE2020

High prevalence of pituitary deficiency after cranial radiation therapy for skull base meningioma: The importance of an annual screening.

Raymond Perrine , Cuny Thomas , Klein Marc , Bernier-Chastagner Valerie

Purpose: To determine the risk of developing hypopituitarism after cranial irradiation for skull base meningiomas. Cranial irradiation is often chosen as first treatment in skull base meningiomas to avoid risk to proximally-located critical structures. While cranial irradiation has been associated with high risk of inducing hypopituitarism, few studies concern meningiomas.Methods and materials: Fifty-two adult patients receiving photon-beam therapyfor sk...

ea0032p511 | Endocrine tumours and neoplasia | ECE2013

Investigation of novel chemotherapeutic combinations in a tumor model for adrenocortical carcinoma

Jung Sara , Hantel Constanze , Mussack Thomas , Reincke Martin , Beuschlein Felix

Medical treatment of adrenocortical carcinoma (ACC) is limited to common cytotoxic agents, which are usually given in combination with mitotane (M). Recently, we investigated together with M the effects of i) the classical EDP protocol (etoposide, doxorubicin, and cisplatin) and ii) a novel paclitaxel containing scheme PDP (paclitaxel, doxorubicin, and cisplatin) on human NCIh295 cells indicating anti-tumoral superiority of PDP-M over EDP-M regarding cell viability (P...

ea0032p886 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Short-term exercise-induced GH response in athletes: differential results for runners and bikers when tested on bicycle

Zueger Thomas , Bucher Julie , Christ Emanuel , Stettler Christoph

Background/introduction: SUB:Pituitary – Clinical (Generously supported by IPSEN)We have previously shown that GH assessment during a standardized aerobic exercise of moderate intensity is a reliable test with high diagnostic accuracy in predicting severe GH deficiency (GHD) in adult individuals. However, these studies comprised comparably long exercise durations around 60 min or longer. To improve clinical applicability of exercise testing in the diagnosis of GH...

ea0031p33 | Bone | SFEBES2013

Osteogenic malignancy and severe vitamin D deficiency (osteogenic osteomalacia)

Postlethwaite Carol , Thomas Amy , Goulden Peter , Kumar Jesse

Introduction: Vitamin D deficiency is increasingly being recognized as a metabolic disorder in temperate climates with various bone, cardiovascular and systemic manifestations. However topical, it is important to exclude tumour induced osteogenic osteomalacia as a possible aetiology in severe vitamin D deficiency when other risk factors (vegetarian diet, ethnicity, etc.) are absent. Early diagnosis of malignant tumors could be life saving and their resection may make this vita...

ea0031p337 | Steroids | SFEBES2013

Osteoporosis prophylaxis in medical patients taking corticosteroids

Carter Thomas , Simons Angeline , Nutt James , Smith Beng , Raja Maduri

Background: Oral corticosteroids are a known risk factor for developing osteoporosis and subsequent fracture at higher bone mineral density than post menopausal osteoporosis. Bone loss is thought to be most pronounced in the first 12 weeks of steroid use, and existing guidelines recommend a fracture risk assessment and appropriate osteoporosis prophylaxis with calcium and vitamin D supplements and bisphosphonates. There is also a recognized role for FRAX scoring to help strati...

ea0031p339 | Steroids | SFEBES2013

Spot urine cortisol: creatinine ratio: a useful screening test for patients with Cushing's syndrome

Paul Thomas , Kapoor Nitin , Job Victoria , Lakshmanan Jeyaseelan , Rajaratnam Simon

Introduction: Cushing’s syndrome(CS) is associated with high morbidity and mortality which warrants a good screening test that is less laborious. We explored the possibility of using urine spot cortisol:creatinine ratio (UCCR) as a new screening test for Cushing’s syndrome.Aims and objectives: To study the efficacy of UCCR as a screening test for patients with Cushing’s syndrome.To compare UCCR in patients with CS, o...